In the article, “Treatment of a stage III rima glottidis patient with the oncolytic virus Rigvir: A retrospective case report”,[ which appears in Volume 98, Issue 45 of Medicine, the second quotation in 4.2. Ethical approval is written incorrectly and should be “different indication in term of medical condition than the one described in the authorised product information; a different group of patients than the one described in the authorised product information; a different route or method of administration than the one described in the authorised product information; a different posology than the one described in the authorized product information.”